Cardiovascular Risk and Metabolic Syndrome Characteristics in Patients with Nonfunctional Pituitary Macroadenoma

Table 3

Risk stratification according to gender.

Globorisk score	Total group ()		Male ()		Female ()
	At diagnosis	At the last visit	At diagnosis	At the last visit	At diagnosis	At the last visit
<3 points	15%	15%	45%	36%	54%	63%
3–10 points	39%	49%	50%	65%	50%	34%
>10 points	45%	35%	81%	72%	18%	28%

: men versus women at diagnosis, : men versus women after multimodal treatment at the last visit.